ARTICLE
11 April 2014

FDA Issues Guidance On Financial Interests

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The FDA announced a guidance document on the"Public Availability of Advisory Committee Members' Financial Interest Information and Waivers".
United States Food, Drugs, Healthcare, Life Sciences

In the March 31 Federal Register, FDA announced a guidance document entitled Guidance for the Public, Food and Drug Administration Advisory Committee Members, and Food and Drug Administration Staff: Public Availability of Advisory Committee Members' Financial Interest Information and Waivers. The guidance replaces a 2012 version and provides forms to facilitate disclosures and potential waivers of conflicts of interest for advisory committee members.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More